Sequencing Bispecific Agents in a Rapidly Evolving Multiple Myeloma SpaceByIra Zackon, MDDecember 9th 2024Using bispecific antibodies before or after CAR T-cell therapy in multiple myeloma is an area of education for community oncologists.